Galapagos NV: business update: http://t.co/6w1jppWE
posted 5 days ago
FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
Patrik De Haes has been appointed as the new chairman of the Board of Directors of FlandersBio. He succeeds Johan Cardoen who stands down after five years in the post. Patrik De Haes, who is the CEO of ThromboGenics, has been a director of FlandersBio for the last two years. read more
Na 3,5 succesjaren geeft Ann Van Gysel begin 2012 de fakkel door aan Ann De Beuckelaer als nieuwe Algemeen Directeur van FlandersBio, de netwerkorganisatie die sinds 2004 de drijvende kracht is voor de stevige groei van de Vlaamse kennisgebaseerde biotechindustrie. read more
